Skip to Content Facebook Feature Image

AI Infrastructure Company EverMind's EverMemOS Aims to Give AI Agents Durable, Coherent, and Continuously Evolving "Souls"

Business

AI Infrastructure Company EverMind's EverMemOS Aims to Give AI Agents Durable, Coherent, and Continuously Evolving "Souls"
Business

Business

AI Infrastructure Company EverMind's EverMemOS Aims to Give AI Agents Durable, Coherent, and Continuously Evolving "Souls"

2025-12-09 16:11 Last Updated At:16:35

SAN MATEO, Calif., Dec. 9, 2025 /PRNewswire/ -- AI infrastructure company EverMind has announced a major milestone in long-term memory research with its newly released EverMemOS achieving 92.3% accuracy on LoCoMo and 82% on LongMemEval-S—two of the field's most authoritative benchmarks. The results significantly surpass prior methods and establish a new State-of-the-Art for durable, coherent machine memory. Developed with the mission of building the memory layer for future intelligence, EverMemOS now powers Tanka and is designed to equip more AI agents with stable identities that evolve through time, enabling them to develop durable, coherent, continuously growing "souls."

A Paradigm Shift Inspired by Human Cognition

EverMemOS's core design stems from an insight shared by entrepreneur and philanthropist Chen Tianqiao at the Tianqiao and Chrissy Chen Institute's Symposium for AI Accelerated Science (AIAS 2025) in San Francisco this October. Chen contrasted current AI's "spatial structure" paradigm, which is instantaneous, static, and reliant on massive spatial parameters, with the human brain's "temporal structure" paradigm: continuous, dynamic, and built to manage time-based information. Long-term memory, he argued, is the linchpin connecting time and true intelligence. EverMemOS was born from this idea: a system engineered to give AI temporal continuity—the ability to remember, adapt, and grow over time.

Three Innovations Redefining AI Memory

EverMemOS stands out through three industry-first innovations that solve longstanding memory limitations.

Its first innovation is a shift from treating memory as static storage to enabling it as an active, applied capability. Conventional methods retrieve information but do not integrate it into reasoning. EverMemOS, by contrast, uses unique fusion and decision mechanisms that allow memory to continuously influence a model's thinking and outputs. Each interaction draws on contextual history, enabling consistent, stable, and personalized experiences across time.

The second innovation is its hierarchical memory extraction and dynamic organization engine. Rather than storing memories as unstructured text fragments, EverMemOS converts them into semantic MemCells and organizes them within evolving memory graphs. This strategy links related ideas, overcomes the limitations of similarity-based retrieval, and provides a structured foundation for complex downstream applications such as reasoning-driven agents, professional assistants, and emotionally aware companion models.

A third innovation lies in EverMemOS's extensible modular memory framework, the first of its kind designed to meet diverse real-world needs. Memory requirements differ across scenarios: professional tasks demand precise, structured information; companionship models require empathetic, emotionally aware context; and agentic workflows rely on continuity and task-specific recall. EverMemOS adapts to each case, selecting the optimal memory organization and application strategy. This flexibility helps address the long-standing challenge posed by rigid, single-form memory systems and enables AI to operate effectively across varied environments.

Flexible Service Models for Every User

EverMind will offer EverMemOS in multiple service formats to fit different levels of technical capability. At present, an open-source version allows experienced developers to deploy and maintain the system independently. Later this year, a cloud-service version will be released to offer free trials and subscription-based access, with no operational overhead. A custom deployment version will support strategic partners seeking tailored integrations. A personal version, built for hardware-integrated and MCP-enabled contexts, will extend long-term memory capabilities to individual use cases.

EverMind is working to advance the foundation of artificial intelligence by addressing one of its most fundamental limitations: the lack of long-term memory. Through EverMemOS, the company introduces a scalable, customizable memory architecture that enables AI to operate with extended context, maintain behavioral consistency, and improve through continuous interaction. As AI systems move toward greater persistence, adaptability, and identity formation, EverMemOS is designed to serve as a reliable memory layer supporting the next generation of intelligent agents.

About EverMind

EverMind is redefining the future of AI by solving one of its most fundamental limitations: long-term memory. Its flagship platform, EverMemOS, introduces a breakthrough architecture for scalable and customizable memory systems, enabling AI to operate with extended context, maintain behavioral consistency, and improve through continuous interaction.

To learn more about EverMind and EverMemOS, please visit:

Website: https://evermind.ai/
GitHub: https://github.com/EverMind-AI/EverMemOS
X: https://x.com/EverMindAI
Reddit: https://www.reddit.com/r/EverMindAI/  

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

AI Infrastructure Company EverMind's EverMemOS Aims to Give AI Agents Durable, Coherent, and Continuously Evolving "Souls"

AI Infrastructure Company EverMind's EverMemOS Aims to Give AI Agents Durable, Coherent, and Continuously Evolving "Souls"

BEIJING, March 10, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at advancing the field of synthetic biology. This collaboration brings together the strengths of both companies to drive innovation, streamline product development, and expand market reach.

Harnessing Expertise to Transform the Industry

Synthetic biology is rapidly emerging as a transformative field with wide-reaching applications, including precision medicine, bio-breeding, and gene editing. At the core of these advancements are high-throughput and column-based synthesis, which Tsingke Biotech and iGeneTech aim to further develop.

Tsingke Biotech, a leader in gene synthesis, has developed a fully integrated industrial chain that spans raw materials, equipment, process design, AI, and digital technologies. Known for its scalability, standardization, and stability, the company's cutting-edge technology includes column synthesis and an intelligent factory-driven production system that supports from small-scale laboratory production (2nmol) to large-scale industrial synthesis (12mmol). Their gene synthesis services include:

  • Primer Synthesis (<300nt)
  • Gene Synthesis (300bp–5kb)
  • Long Gene Synthesis (>5kb)

On the other hand, iGeneTech contributes its proprietary Ignite 3.0 high-throughput synthesis platform. With its ability to process oligo pools ranging from 4k to 650k in size and achieve synthesis lengths up to 200nt with error rates as low as 0.2%, this platform addresses key challenges around throughput, speed, and cost.

A Shared Vision for Growth

"We are excited to partner with iGeneTech, whose expertise in gene capture and next-generation sequencing (NGS) technology enhances our strengths in gene synthesis," said Mr. Shijin Ma, CEO of Tsingke Biotech. "This partnership will speed up the translation of technological innovations into real-world applications, helping drive the industry forward."

Mr. Wanshi Cai, CEO of iGeneTech, added, "Tsingke Biotech's integrated industrial chain and leadership in gene synthesis will be crucial in supporting our continued growth. Together, we will push the boundaries of synthetic biology and its potential across various industries."

Both companies are committed to developing an integrated system that spans the entire spectrum from "synthesis" to "application," focusing on innovation, sustainability, and precision to meet the needs of a rapidly evolving market.

About Tsingke Biotech

Tsingke Biotech is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven molecular manufacturing technologies, Tsingke Biotech provides efficient and high-quality gene synthesis services. Its work supports industries ranging from biopharma to agriculture, food, and environmental sciences.

About iGeneTech

iGeneTech specializes in gene capture technologies and holds intellectual property in NGS probe hybridization, multiplex PCR, and high-throughput DNA synthesis. The company's high-quality oligo pool synthesis capabilities enable the creation of precise and uniform sgRNA libraries for gene-editing applications, including genome-wide and target-gene sgRNA libraries, and off-target detection.

Contact: market@tsingke.com.cn 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements

Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements

Recommended Articles